Retina Associates, Ltd.
Elmhurst, Illinois 60126
4 studies enrolling now · 8 studies all time
What they study most
Age - Related Macular Degeneration (AMD), Diabetes Mellitus, Diabetic Macular Edema, Diabetic Retinopathy, Geographic Atrophy, Geographic Atrophy (GA), Macular Edema Secondary to Inflammation, Neovascular Age-Related Macular Degeneration (nAMD), Rhegmatogenous Retinal Detachment - Macula Off, Wet Age-related Macular Degeneration
Studies at this site
- Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD — Recruiting now
- A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE — Recruiting now
- A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK — Recruiting now
- Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration — Recruiting now
- A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) — Running, not enrolling
- A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK — Running, not enrolling
- A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Mac-off Retinal Detachment — Completed
- A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema. — Stopped early